TY  - GEN
AU  - LaMontagne,Kenneth R
AU  - Butler,Jeannene
AU  - Borowski,Virna B
AU  - Fuentes-Pesquera,Angel R
AU  - Blevitt,Jonathan M
AU  - Huang,Shenlin
AU  - Li,Ronghua
AU  - Connolly,Peter J
AU  - Greenberger,Lee M
TI  - A highly selective, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor has potent activity in vitro and in vivo
SN  - 1573-7209
PY  - 2010///0111
KW  - Administration, Oral
KW  - Angiogenesis Inhibitors
KW  - administration & dosage
KW  - Animals
KW  - Cell Movement
KW  - drug effects
KW  - Cells, Cultured
KW  - Endothelial Cells
KW  - Female
KW  - HCT116 Cells
KW  - Humans
KW  - Mice
KW  - Mice, Inbred C57BL
KW  - Mice, Nude
KW  - Mice, Transgenic
KW  - Models, Biological
KW  - Neoplasms
KW  - drug therapy
KW  - Oximes
KW  - Phenylurea Compounds
KW  - Protein Kinase Inhibitors
KW  - Substrate Specificity
KW  - Vascular Endothelial Growth Factor A
KW  - pharmacology
KW  - Vascular Endothelial Growth Factor Receptor-2
KW  - antagonists & inhibitors
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1007/s10456-009-9151-7
ER  -